Amphastar Pharmaceuticals, Inc. (AMPH)
29.37
+0.50
(+1.73%)
USD |
NASDAQ |
Nov 13, 16:00
29.38
0.00 (0.00%)
After-Hours: 19:59
Amphastar Pharmaceuticals Price to Book Value : 1.538 for Nov. 13, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 13, 2026 | 1.538 |
| November 12, 2026 | 1.512 |
| November 11, 2026 | 1.497 |
| November 10, 2026 | 1.522 |
| November 09, 2026 | 1.538 |
| November 06, 2026 | 1.492 |
| November 05, 2026 | 1.448 |
| November 04, 2026 | 1.467 |
| November 03, 2026 | 1.420 |
| November 02, 2026 | 1.415 |
| October 30, 2026 | 1.451 |
| October 29, 2026 | 1.41 |
| October 28, 2026 | 1.379 |
| October 27, 2026 | 1.339 |
| October 26, 2026 | 1.334 |
| October 23, 2026 | 1.316 |
| October 22, 2026 | 1.363 |
| October 21, 2026 | 1.372 |
| October 20, 2026 | 1.358 |
| October 19, 2026 | 1.369 |
| October 16, 2026 | 1.354 |
| October 15, 2026 | 1.383 |
| October 14, 2026 | 1.366 |
| October 13, 2026 | 1.364 |
| October 12, 2026 | 1.401 |
| Date | Value |
|---|---|
| October 09, 2026 | 1.394 |
| October 08, 2026 | 1.351 |
| October 07, 2026 | 1.337 |
| October 06, 2026 | 1.357 |
| October 05, 2026 | 1.328 |
| October 02, 2026 | 1.332 |
| October 01, 2026 | 1.327 |
| September 30, 2026 | 1.351 |
| September 29, 2026 | 1.477 |
| September 28, 2026 | 1.517 |
| September 25, 2026 | 1.447 |
| September 24, 2026 | 1.454 |
| September 23, 2026 | 1.382 |
| September 22, 2026 | 1.347 |
| September 21, 2026 | 1.355 |
| September 18, 2026 | 1.308 |
| September 17, 2026 | 1.319 |
| September 16, 2026 | 1.326 |
| September 15, 2026 | 1.309 |
| September 14, 2026 | 1.324 |
| September 11, 2026 | 1.317 |
| September 10, 2026 | 1.303 |
| September 09, 2026 | 1.276 |
| September 08, 2026 | 1.270 |
| September 04, 2026 | 1.284 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Viatris, Inc. | 1.744 |
| Johnson & Johnson | 8.437 |
| Eli Lilly & Co. | 33.74 |
| Merck & Co., Inc. | 8.119 |
| Pfizer Inc. | 1.850 |
Price to Book Value Related Metrics
| PE Ratio | 13.27 |
| PS Ratio | 1.784 |
| Price to Free Cash Flow | 29.89 |
| Price | 29.37 |
| Earnings Yield | 7.53% |
| Market Cap | 1.253B |
| Operating PE Ratio | 9.522 |
| Normalized PE Ratio | 14.92 |